...
...
PHUSE collaborations are organised into a number of specialist Working Groups, each with a broad topic area. The Working Groups have specific projects designed to achieve a set of particular objectives. This page will highlight the latest news and information from our projects. Participation is open to anyone who wants to contribute and if you would like to get involved, please email workinggroups@phuse.global. |
|---|
...
...
PHUSE/FDA CSS
...
.jpg?version=1&modificationDate=1684226707693&cacheVersion=1&api=v2&width=550)
...
...
The Safety Analytics Working Group will be delivering a series of virtual, free to attend webinars over the coming months. The second webinar took place on 13 July on the topic of Overall Safety Assessment – Standard Safety Tables and Figures. Click here to view the slides! A list of all upcoming webinars can be found here.
...
.jpg?version=1&modificationDate=1686051108095&cacheVersion=1&api=v2&width=550)
...
...
The Real World Evidence Working Group hosted a Community Forum on Designing your RWD Study: Is Your Data Fit For Purpose? Rest assured if you couldn't attend, the recording is available to view now!
...
Volunteer Opportunities
...
The Nonclinical Topics Workings Group’s new project. Nonclinical Protocol Automation is now calling for volunteers. This project plans to determine the feasibility of transforming the BioCelerate Nonclinical Protocol Template into a dynamic Microsoft Word document where filling in the template allows output of all fields for machine readability. Determine the feasibility of expanding the OpenStudyBuilder system for nonclinical study usage. Explore the output and API functionality of this system. Based upon conclusions from the above, work with one or both groups to complete a pilot for creating a few model study designs for demonstration of protocol automation.
Real World Evidence Working Group’s new project Real World Data Guideline/White Paper for Statistical Programmers is now calling for volunteers. The aim of this project is for statistical programmers across pharma to collaborate and provide their input to create an RWE Guideline/White Paper for the industry.
Please contact workinggroups@phuse.global to register your interest in volunteering.
Call for Working Group Leads
...
Multiple projects within Working Groups are open to join. PHUSE welcomes new members who can apply their knowledge to bring fresh ideas and contribute to the ongoing work of PHUSE projects. For more information, click here, read the Welcome Pack or email workinggroups@phuse.global.
...
The Julia Initiative for High Performance Computing Project have produced a White Paper providing an overview of Julia's features and benefits for high performance computing, including its fast compilation, dynamic typing, multiple dispatch, and built-in support for parallelism. This paper also discusses current real-world use cases of Julia and potential case studies for high performance computing. The team are calling for feedback on the White Paper, please provide any comments to workinggroups@phuse.global by 7 August.
The Centralised Monitoring Capabilities Project has produced a White Paper focusing on the value of CM as it relates to the protection of data integrity and quality. This paper also explores the subsequent considerations and challenges in demonstrating this value and has leveraged the industry survey conducted by the Project – exploring case studies and review of industry literature. The team are calling for feedback on the White Paper, please provide any comments to workinggroups@phuse.global by 28 July.
...
The Bio-research Monitoring Data Reviewer's Guide project has updated their Data Reviewer’s Guide Template (BDRG). Version 3.0 of the BDRG provides regulatory agency reviewers an orientation to the submitted Bioresearch Monitoring (BIMO) data in a consistent way and usable format. The BDRG Package includes an Introduction and Overview, Template, Completion Guidelines and Examples.
The Comparing Analysis Method Implementations in Software (CAMIS) Project has published their White Paper titled 'Key Considerations When Understanding Differences in Statistical Methodology Implementations Across Programming Languages – An Introduction to the CAMIS Project'. This White Paper aims to empower clinical data scientists to make informed choices on the implementation of statistical analyses when multiple languages yield different results.
...
Working Groups Q1 Reports |
|---|
We’re excited to share the latest update highlighting the fantastic progress across our Working Groups. This quarter’s report showcases key achievements from our Projects and highlights the important and innovative work that’s still underway. Explore the full report to see how each Project is making an impact—and don’t miss the detailed overview of the events and milestones that shaped this quarter’s journey. |
...
pharmaverse | ||
|---|---|---|
pharmaverse Hackathon Series Featuring the {xportr} Package Hackathon Kick-Off – 12 May 09:00–10:00 (EDT) / 14:00–15:00 (BST) / 15:00–16:00 (CEST)
|
Real World Evidence | ||
|---|---|---|
Webinar: Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes 21 May 11:00-12:00 (EDT) / 16:00-16:00 (BST) / 17:00-18:00 (CEST)
|
Data Transparency Autumn Event – Call For Speakers | ||
|---|---|---|
The Data Transparency Working Group invites abstract submissions for its upcoming multi‑day virtual event, taking place 15–17 September 2026 at 10:00–12:30 (EDT) / 15:00–17:30 (BST) / 16:00–18:30 (CEST). The event will focus on the evolving landscape of clinical data transparency, including approaches to data sharing, anonymisation, governance and enabling responsible access to clinical data. Focus your submission on these central themes and submit an abstract by 8 May to contribute to the discussion. Click here for more information.
|
Real World Data Autumn Event – Call For Speakers | ||
|---|---|---|
We’re excited to announce Call for Speakers for the Real World Evidence Working Group’s second multi‑day virtual event is now open! Taking place 30 September – 1 October 2026, from 09:00–11:30 (EDT) / 14:00–16:30 (BST) / 15:00–17:30 (CEST). Submit your abstract by 8 May for the chance to present. Focus your submission on these central themes:
Click here for more information.
|
...
Emerging Trends & Innovation |
|---|
The Integration of Omics Data into Clinical Drug Development project within the Emerging Trends & InnovationWorking Group has published a new White Paper titled “Capturing Computational Workflows in Clinical Trials with BioCompute” This white paper explores how the BioCompute framework can transform the way computational workflows are captured and communicated in clinical trials. As bioinformatics analyses become increasingly complex, consistent and transparent documentation is essential for reproducibility and regulatory confidence. Through practical case studies, the paper demonstrates how BioCompute enables structured, auditable workflows across diverse data types, including omics and imaging, while supporting more efficient collaboration and regulatory submissions. |
Real World Evidence |
|---|
The RWD Guideline for Programming and Analysis Processes Project within the Real World Evidence Working Group has published a new White Paper. This paper offers practical guidance for statistical programmers on applying real‑world data (RWD) to produce regulatory‑grade real‑world evidence (RWE), covering study design, data fitness, governance, ethics, vendor engagement, bias management, and regulatory submission considerations. |
...
Real World Evidence – Calling For Feedback |
|---|
The Quality and Reusability of Real World Data Project within the Real World Evidence Working Group has produced a White Paper ‘Real-World Data Reliability and Integrity: Ensuring Real-World Data is Fit for Use for Regulatory Submissions’. This White Paper focuses on the usability of real-world data sources for regulatory submission purposes. To assess the fit for use of this data, we need to assess the relevance and the reliability of the data. Please provide your comments by emailing workinggroups@phuse.global. Closing date for comments: 1 May 2026. |
Data Transparency – Calling For Feedback |
|---|
The EU CTR Implementation Project within the Data Transparency Working Group has finalised the White Paper ‘Protecting Commercially Confidential Information (CCI) While Complying with the European Union Clinical Trials Regulation 536/2014’. This White Paper offers clear, practical guidance to help clinical trial sponsors navigate the EU Clinical Trials Regulation while safeguarding commercially confidential information (CCI). Please provide your comments by emailing workinggroups@phuse.global. Closing date for comments: 6 May 2026. |
Nonclinical Topics – Calling For Feedback |
|---|
The Conformance with the tumor.xpt Specification within the Nonclinical Topics Working Group has produced a White Paper ‘Conformance with the Technical Specifications Document for Submitting Nonclinical Datasets for Evaluation of Rodent Carcinogenicity Studies of Pharmaceuticals’ along with a set of Conformance Rules. This White Paper outlines the development of standardised conformance rules for tumor.xpt datasets to enable automated validation, improve data consistency, and reduce manual effort in regulatory submissions for carcinogenicity studies.. Please provide your comments by emailing workinggroups@phuse.global. Closing date for comments: 20 May 2026. |
...
If you would like to get involved in a PHUSE Working Group Project, please explore the projects via the Volunteer Board and contact the PHUSE Office on workinggroups@phuse.global to express your interest. |
...
Working Group Report: Includes project updates, recent and upcoming deliverables and future plans for each Working Group. | |
Monthly Mailings: The monthly newsletter. Here you will find a full update from each month of the year, easily accessible and divided into key areas of PHUSE. | |
PHUSE Blogs: Fancy a quick read? A blog is a perfect way to catch up on all things Working Groups. Get the lowdown on the latest events from across the globe and stay updated on industry topics brought to you by industry professionals. |
...
Initiate and lead a new project under the PHUSE Working Groups umbrella. The new project must address problems of significant relevance to computational science related to drug, |
...
biological and device development and must meet all of the guidelines for projects within the collaboration, including the following mandatory requirements:
New projects can be submitted anytime during the year, click here to submit |
...
...
Working Groups Report: Includes project updates, recent and upcoming deliverables and the future plans for each Working Group.
...
Monthly Mailings: The monthly newsletter. Here you will find a full update from each month of the year, easily accessible and divided into key areas of PHUSE.
...
. |